title: New anticoagulants & clinical trials.
abstract: This article reviews for early 2009 the pharmacology and indications of approved newer anticoagulants and also briefly reviews agents being tested in clinical trials.
authors.affiliation: Division of Hematology and Oncology, University of Missouri-Kansas City School of Medicine, USA.
authors.forename: Nisreen
authors.initials: N
authors.lastname: Haideri
authors.forename: Hitendra
authors.initials: H
authors.lastname: Patel
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011956:Receptors, Cell Surface; D013917:Thrombin / Q000037:antagonists & inhibitors; D013923:Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D011956:Receptors, Cell Surface; C091963:activated protein C receptor; D014859:Warfarin; D013917:Thrombin